博客

其他健康状况

Thrombate III :用途、剂量、副作用、警告及其他

血栓的三维示意图,血栓是一种可用Thrombate III治疗的疾病。

Thrombate III is an FDA-approved drug used to treat and prevent blood clots in patients with hereditary antithrombin deficiency (hATd), a rare genetic blood-clotting disorder in which a patient has insufficient or dysfunctional antithrombin (AT), a protein that helps prevent excessive blood clotting. 

您是否符合 $0 共付额资格?

立即了解
(877) 778-0318

Hereditary antithrombin deficiency is often undiagnosed and affects around 66,200 people in the United States. 

Thrombate III is also known by its generic name, antithrombin III (human), and is produced from donated human blood plasma. 

Read on to learn how Thrombate III works, when it is prescribed, its potential side effects, and precautions to consider before receiving treatment. 

Thrombate III: FDA-Approved Uses

Thrombate III (antithrombin III [human]) is approved for use in adults and children with hereditary antithrombin deficiency (hATd) to treat and prevent thromboembolism. Thromboembolism occurs when a blood clot forms, breaks loose, and travels through the bloodstream, potentially blocking another blood vessel.  

Thrombate III can be administered to help prevent thromboembolism before, during, and after surgery (perioperative) and around childbirth (peripartum). 

Warning for Patients or Caregivers

Thrombate III is made from donated human blood. Although donated plasma is screened and Thrombate III undergoes manufacturing processes designed to reduce the risk of transmitting infections, a small risk of transmitting viruses or other infectious agents remains. You can talk to your care team if you have questions about the risk of infection.

作用方式

People with hereditary antithrombin deficiency (hATd) have a higher risk of developing an abnormal blood clot during surgery or childbirth due to a lack of sufficient antithrombin (AT) protein. 

Thrombate III temporarily replaces the missing or deficient antithrombin protein, helping regulate blood clotting and reduce the risk of abnormal blood clots. 

Thrombate III: Drug Form

Thrombate III (antithrombin III [human]) is available in a lyophilized powder form and is supplied as a single-dose vial. Each Thrombate III vial contains approximately 500 IU of antithrombin, which is mixed with 10 ml of sterile water before administration. 

剂量和用法

The dose of Thrombate III you receive is based on your body weight and the amount of antithrombin in your blood before therapy starts. The Thrombate III regimen involves three phases:

  • Loading dose (first dose): The doctor calculates and administers the first dose to raise the antithrombin activity level to approximately 120% of normal. For example, if the patient’s antithrombin level is 50%, the doctor calculates the dose needed to raise it to 120%.
  • Dose adjustment: After giving the medicine, the doctor checks the patient’s blood to see how much the antithrombin level has increased. The target is to maintain the level between 80% and 120% of normal. If the level is too low or too high, the doctor adjusts the dose as needed.
  • Maintenance dose (follow-up doses): The follow-up dose is initially about 60% of the first dose, usually given every 24 hours. The doctor may change the dose depending on blood test results. The target is still to maintain the level between 80% and 120% of normal.

Thrombate III is administered through an 静脉输液 by a healthcare provider.  It may take 10–20 minutes for the full dose to enter the bloodstream through an IV line. 

立即获得共付额援助

安排咨询

与其他药物的相互作用

Thrombate III can interact with heparin, an anticoagulant. When Thrombate III is administered with heparin, it can increase heparin’s anticoagulant effects and raise the risk of excessive bleeding. 

If you’re taking heparin, your doctor may reduce your heparin dose and monitor you closely to help prevent bleeding.

Reported Side Effects

Woman rubbing eyes due to dizziness from a side effect of taking Thrombate III

Side effects reported in patients receiving Thrombate III include: 

  • 口味改变
  • 胸部不适
  • 发冷或发烧
  • 头晕
  • Muscle pain or cramps
  • 恶心

Although these side effects usually do not require immediate medical attention, consult your healthcare provider if they continue or are bothersome. 

In rare cases, Thrombate III may cause some severe adverse effects which include:

  • Allergic reactions such as skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • 呕吐物中带血或呈类似咖啡渣的褐色物质
  • Red or dark brown urine
  • Small red or purple spots on the skin
  • 异常瘀伤或出血
  • Transmission of infectious agents, including the agent responsible for variant Creutzfeldt-Jakob disease (vCJD) 

Seek immediate medical attention if you experience difficulty breathing, swelling of the face or throat, or other signs of a severe allergic reaction. 

预防措施

Before receiving Thrombate III, tell your healthcare provider if you: 

  • Have had an allergic reaction to antithrombin III or any other medication. 
  • Are pregnant or trying to get pregnant. It is not known if Thrombate III will harm your unborn baby. 
  • Are breastfeeding or plan to breastfeed. It is not known if Thrombate III passes into breast milk. 
  • Take other medications, including anticoagulants such as heparin, over-the-counter medicines, vitamins, or herbal supplements. 

与专家交谈

关于共付额援助
(877) 778-0318

预计费用

The cost of Thrombate III can vary depending on several factors, including the number of doses required, the duration of treatment, your location, and your insurance coverage. According to a 2017 report, a 500 IU vial of Thrombate III cost approximately $2,330 at the time. 

联系我们 if you are interested in possible financial assistance or copay assistance for Thrombate III.

参考:

  1. THROMBATE III® (antithrombin III [human]) 处方信息. Grifols. https://grifolsug-pi.com/inserts/Thrombate.pdf
  2. US Food and Drug Administration (FDA). THROMBATE III® (antithrombin III [human]) 处方信息: https://www.fda.gov/media/188338/download?attachment
  3. Rodgers, G. M., & Mahajerin, A. (2023). Antithrombin Therapy: Current State and Future Outlook. Clinical and Applied Thrombosis/Hemostasis, 29, 10760296231205279. https://doi.org/10.1177/10760296231205279
  4. Ciolek, A., Lindsley, J., Crow, J., Nelson-McMillan, K., & Procaccini, D. (2017). Identification of Cost-Saving Opportunities for the Use of Antithrombin III in Adult and Pediatric Patients. Clinical and Applied Thrombosis/Hemostasis, 24(1), 186. https://doi.org/10.1177/1076029617693941
此信息不能替代医疗建议或治疗。在开始任何新的治疗之前,请咨询您的医生或医疗保健提供者,了解您的医疗状况。AmeriPharma® Specialty Care 对所提供的信息或由此做出的任何诊断或治疗不承担任何责任,也不对其内容的可靠性负责。AmeriPharma® Specialty Care 并非运营此处列出的所有网站/组织,也不对其内容的可用性或可靠性负责。这些列表并不暗示或构成 AmeriPharma® Specialty Care 的认可、赞助或推荐。本网页可能包含对品牌处方药的引用,这些处方药是与 AmeriPharma® Specialty Care 无关的制药商的商标或注册商标。
这是萨曼莎·K的肖像,她是一名医疗保健专业人员或患者代表。.
医学审核人 Samantha Kaeberlein 博士,药学博士

Samantha Kaeberlein 博士,药学博士,在俄亥俄州坎顿出生长大。她于 2020 年获得东北俄亥俄医科大学 (NEOMED) 的药学学位。她工作中最有意义的部分是提供医疗指导,帮助患者做出明智、全面的医疗保健决策。她的专业领域是老年医学和长期护理。闲暇时,她喜欢户外活动、阅读,以及寻找美国最好的咖啡。

联系我们

如果您有兴趣与专家交谈或希望了解经济援助机会,请使用下面的联系表格与我们联系。.

符合 HIPAA 标准

提交即表示您同意 AmeriPharma 的 使用条款, 隐私政策, 和 隐私惯例通知